Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
Diabetes, Obesity & Metabolism
|
June 18, 2021
Use of once-weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study
Jean-François Yale, Andrei-Mircea Catarig, Katrine Grau, et al.
Medicine and Science in Sports and Exercise
|
January 20, 2010
Nutrition and exercise prevent excess weight gain in overweight pregnant women
Michelle F Mottola, Isabelle Giroux, Robert Gratton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 2, 2024
The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation
Kirk Szafranski, Gerard De Pouvourville, Dan Greenberg, et al.
BMC Health Services Research
|
March 25, 2017
The FORGE AHEAD clinical readiness consultation tool: a validated tool to assess clinical readiness for chronic disease care mobilization in Canada's First Nations
Mariam Naqshbandi Hayward, Selam Mequanint, Jann Paquette-Warren, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 14, 2020
Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin
Natalia McInnes, Stephanie Hall, Farah Sultan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
December 27, 2022
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, et al.
Diabetes, Obesity & Metabolism
|
October 25, 2019
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study
Alice Cheng, Stewart Harris, Francesco Giorgino, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
December 15, 2018
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis
Keith Bowering, Helena W Rodbard, David Russell-Jones, et al.
Drugs
|
January 22, 2020
Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes
Stewart Harris, Martin J Abrahamson, Antonio Ceriello, et al.
BMJ Open
|
June 10, 2024
Evaluation of a unique and innovative diabetes care model in primary care in Ontario, Canada: protocol for a multiple-methods study with a convergent parallel design
Maria Mathews, Rhiannon Lyons, Stewart Harris, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
Diabetes, Obesity & Metabolism
|
June 18, 2021
Use of once-weekly semaglutide in patients with type 2 diabetes in routine clinical practice: Results from the SURE Canada multicentre, prospective, observational study
Jean-François Yale, Andrei-Mircea Catarig, Katrine Grau, et al.
Medicine and Science in Sports and Exercise
|
January 20, 2010
Nutrition and exercise prevent excess weight gain in overweight pregnant women
Michelle F Mottola, Isabelle Giroux, Robert Gratton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 2, 2024
The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation
Kirk Szafranski, Gerard De Pouvourville, Dan Greenberg, et al.
BMC Health Services Research
|
March 25, 2017
The FORGE AHEAD clinical readiness consultation tool: a validated tool to assess clinical readiness for chronic disease care mobilization in Canada's First Nations
Mariam Naqshbandi Hayward, Selam Mequanint, Jann Paquette-Warren, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 14, 2020
Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin
Natalia McInnes, Stephanie Hall, Farah Sultan, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
December 27, 2022
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers
Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, et al.
Diabetes, Obesity & Metabolism
|
October 25, 2019
Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT study
Alice Cheng, Stewart Harris, Francesco Giorgino, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
December 15, 2018
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis
Keith Bowering, Helena W Rodbard, David Russell-Jones, et al.
Drugs
|
January 22, 2020
Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes
Stewart Harris, Martin J Abrahamson, Antonio Ceriello, et al.
BMJ Open
|
June 10, 2024
Evaluation of a unique and innovative diabetes care model in primary care in Ontario, Canada: protocol for a multiple-methods study with a convergent parallel design
Maria Mathews, Rhiannon Lyons, Stewart Harris, et al.
Page
of 6